Cargando…

Physician pricing and health insurance reimbursement

Detalles Bibliográficos
Autores principales:	Yett, Donald E., Der, William, Ernst, Richard L., Hay, Joel W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CENTERS for MEDICARE & MEDICAID SERVICES 1983
Materias:	Special Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191326/ https://www.ncbi.nlm.nih.gov/pubmed/10310530

Ejemplares similares

Blue Shield Plan Physician Participation
por: Yett, Donald E., et al.
Publicado: (1981)

The impact of Ghana's National Health Insurance Scheme median pharmaceutical pricing methodology and reimbursement policy on the pharmaceutical system
por: Mordi, Dumebi O, et al.
Publicado: (2015)

Pharmaceutical pricing and reimbursement policies: perspectives for the future
por: Gray, Andrew L
Publicado: (2015)

Reimbursement of pharmaceuticals: reference pricing versus health technology assessment
por: Drummond, Michael, et al.
Publicado: (2010)

Public unawareness of physician reimbursement
por: Herrick, Nicole Lilly, et al.
Publicado: (2017)

Pricing and reimbursement of novel oncology drugs in Sweden
por: Haglund, Mattias, et al.
Publicado: (2014)

Challenges and opportunities for pharmaceutical pricing and reimbursement policies
por: Vogler, Sabine, et al.
Publicado: (2015)

Concordance of Disclosed Hospital Prices With Total Reimbursements for Hospital-Based Care Among Commercially Insured Patients in the US
por: Horný, Michal, et al.
Publicado: (2021)

Use of medicine pricing and reimbursement policies for universal health coverage in Indonesia
por: Wasir, Riswandy, et al.
Publicado: (2019)

The evolution of Taiwan’s National Health Insurance drug reimbursement scheme
por: Hsu, Jason C, et al.
Publicado: (2015)

Pricing and reimbursement of orphan drugs: the need for more transparency
por: Simoens, Steven
Publicado: (2011)

Drug pricing and reimbursement decision making systems in Mongolia
por: Dorj, Gereltuya, et al.
Publicado: (2017)

Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries
por: Kawalec, Paweł, et al.
Publicado: (2017)

The timelines for the price and reimbursement authorization in Italy 2018–2020
por: Gallo, Valentina, et al.
Publicado: (2022)

Regarding: “Insurance Reimbursement for Complementary Healthcare Services”
por: Whedon, James M.
Publicado: (2018)

Value-Based Pricing and Reimbursement in Personalised Healthcare: Introduction to the Basic Health Economics
por: Garrison, Louis P., et al.
Publicado: (2017)

Role of Economic Evaluations on Pricing of Medicines Reimbursed by the Italian National Health Service
por: Russo, Pierluigi, et al.
Publicado: (2022)

Mandated Health Insurance and Provider Reimbursement via Private Insurance: Evidence From the Massachusetts Health Reform
por: Friedson, Andrew, et al.
Publicado: (2017)

Health Insurance Reimbursement to Hosptials in Vietnam: Policy Implementation Results and Challenges
por: Ha, Nguyen Thu, et al.
Publicado: (2021)

Approval, reimbursement and pricing of high-cost cancer medicines in Australia
por: Vitry, Agnes
Publicado: (2015)

The reimbursement coverage decisions and pricing rules for medical devices in Taiwan
por: Tsai, Hsin-Yi, et al.
Publicado: (2022)

Reporting reimbursement price decisions for onco-hematology drugs in Spain
por: Elvira, David, et al.
Publicado: (2023)

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
por: Macabeo, Bérengère, et al.
Publicado: (2023)

The Association between Hospital-Physician Vertical Integration and Outpatient Physician Prices Paid by Commercial Insurers: New Evidence
por: Godwin, James, et al.
Publicado: (2021)

Pricing in General Insurance
por: Parodi, Pietro
Publicado: (2014)

Corrigendum to Health Insurance Reimbursement to Hospitals in Vietnam: Policy Implementation Results and Challenges
Publicado: (2021)

Logistics of Rehabilitation Telehealth: Documentation, Reimbursement, and Health Insurance Portability and Accountability Act
por: Chan, Anne H.
Publicado: (2021)

Can Voluntary Health Insurance for Non-reimbursed Expensive New Treatments Be Just?
por: Smids, Jilles, et al.
Publicado: (2023)

Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs
por: Docteur, Elizabeth, et al.
Publicado: (2015)

Comparison of pharmaceutical pricing and reimbursement systems in Turkey and certain EU countries
por: Atikeler, Enver Kagan, et al.
Publicado: (2016)

Reimbursement pricing for new medical devices in Japan: Is the evaluation of innovation appropriate?
por: Tamura, Makoto, et al.
Publicado: (2018)

Pharmaceutical pricing and reimbursement policies in Algeria, Morocco, and Tunisia: comparative analysis
por: Dahmani, Hajer, et al.
Publicado: (2023)

Consumer price sensitivity in Dutch health insurance
por: van Dijk, Machiel, et al.
Publicado: (2008)

Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodies
por: Elvira, David, et al.
Publicado: (2021)

Future Research and Policy Directions in Physician Reimbursement
por: McMenamin, Peter
Publicado: (1981)

Self-Medication Behaviors of Chinese Residents and Consideration Related to Drug Prices and Medical Insurance Reimbursement When Self-Medicating: A Cross-Sectional Study
por: Zhang, Ziwei, et al.
Publicado: (2022)

Can Insurance Market Competition Coexist With Provider Price Regulation? Evidence From Medicare Advantage
por: Berenson, Robert A., et al.
Publicado: (2019)

Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States
por: Vogler, Sabine, et al.
Publicado: (2011)

Cancer Drug Pricing and Reimbursement: Lessons for the United States From Around the World
por: Goldstein, Daniel A., et al.
Publicado: (2016)

Drug pricing and reimbursement information management: processes and decision making in the global economy
por: Tsourougiannis, Dimitrios
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vaqk1ugop9psv02i4u965s3opp